Memorial Sloan Kettering gastroenterologist & hepatologist Maya Gambarin-Gelwan

Maya Gambarin-Gelwan, MD

Gastroenterologist & Hepatologist

Clinical Expertise

Chronic Liver Disease; Liver-related Complications; Viral Hepatitis; Fatty Liver Disease; Liver Cancer

New Patient Appointments

Scheduling a visit is easy. Click below or call us to get started.

Accepted Insurance Providers

Dr. Gambarin-Gelwan accepts the following list of insurance providers. Select your insurance provider to see more details.

Contact and Location

Locations map

Find a Convenient Location

Memorial Sloan Kettering has locations throughout New York City, Long Island, New Jersey, and Westchester. These locations offers many services, including screening, chemotherapy, and medical testing.

About Me


MD, Mount Sinai School of Medicine


Montefiore Medical Center (New York)


Memorial Sloan Kettering Cancer Center; Mount Sinai Medical Center (New York)

Board Certifications

Internal Medicine; Gastroenterology; Transplant Hepatology

I am gastroenterologist and hepatologist who cares for people with a variety of liver diseases, including viral hepatitis B and hepatitis C (HCV), immune-mediated liver diseases, and metabolic liver diseases. I have special expertise in managing these diseases in people with cancer, and in treating liver-related problems from cancer treatments. As a member of Memorial Sloan Kettering’s Hepatopancreatobiliary Disease Management team, I work closely with my colleagues in medical oncology, surgery, radiation oncology, radiology, and pathology to combine our expertise and ensure we are providing our patients with comprehensive personalized care. I am also a strong believer in cancer prevention and early detection, and screening colonoscopy is an integral part of my practice.

I have been practicing since 2005, but my interest in and passion for treating liver diseases goes back much further, when I saw a close friend receive life-saving care and realized that I wanted to go into the field. I went to medical school at a time when hepatitis C was a “new disease” without treatment options. Since then, I have actively contributed my research and knowledge to the field and am proud to say that we are now able to cure most people with this disease.

My current research focuses on how new drugs used to treat hepatitis C can be utilized in patients with active malignancy and how eradication of HCV can affect recurrence of primary liver cancer. I am also interested in studying the affects of certain antihormonal therapies on the development of fatty liver disease in women with a history of breast cancer.

When I meet with patients, they are often concerned with how their disease will progress, and if their liver disease will affect their cancer treatment. I reassure them that we will take things one step at time, starting with a clear understanding of their diagnosis and symptoms. At MSK, we have access to the best tools and treatments, combined with an entire team of doctors, nurses, and support staff who are committed to helping each of our patients get better. 


Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.

Clinical Trials

Smiling doctors in the lab

Find a Clinical Trial for You

Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.

You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.

Research and Publications

Publications on PubMed

Visit PubMed for a full listing of Dr. Gambarin-Gelwan’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.